Literature DB >> 312498

Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.

H A Cooper, K J Clemetson, E F Lüscher.   

Abstract

The platelet membrane receptor for bovine von Willebrand factor, platelet aggregating factor, has been reported to be a property of a soluble glycoprotein, glycocalicin, that is loosely attached to the platelet surface and represents one of the major glycoproteins of the platelet glycocalyx. The studies reported here, however, demonstrate that fractions from human platelets containing glycocalicin have no bovine von Willebrand factor receptor activity. Instead, only fractions containing platelet membranes have receptor activity. By using a nonionic detergent, Brij 99, active receptor can be solubilized from the membrane. Some quantitation of the intact or solubilized receptor activity is possible because the aggregation curves produced by mixtures of various dilutions of membranes and a constant concentration of standard normal bovine plasma are linear when plotted against the logarithm of the concentration of receptor. The dose-response curve obtained with Brij 99-solubilized membranes is not parallel to that obtained with intact membranes. Lectin-specificity studies of the bovine von Willebrand factor receptor, soluble in Brij 99, demonstrate binding to a wheat germ agglutinin-Sepharose 4B affinity gel but little or no binding to similar affinity gels of concanavalin A or Lens culinaris lectin. By using wheat germ agglutinin-Sepharose 4B as a lectin affinity column, partial purification of the receptor is possible. Stability studies of the receptor in intact membranes show essentially no loss of activity for at least 6 days when membranes are stored at 4 degrees C in buffers containing 1 mM EDTA. One freezing and thawing cycle results in minimal loss of initial activity but the receptor activity of the thawed material is less stable over time than is fresh material. Repeated freezing and thawing destroys the activity and, once lost, it can not be recovered, even with detergents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312498      PMCID: PMC383190          DOI: 10.1073/pnas.76.3.1069

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Studies on the metabolism of human blood platelets in relation to clot retraction.

Authors:  M BETTEX-GALLAND; E F LUSCHER
Journal:  Thromb Diath Haemorrh       Date:  1960-03-01

2.  Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease.

Authors:  H J Weiss; H R Baumgartner; T B Tschopp; V T Turitto; D Cohen
Journal:  Blood       Date:  1978-02       Impact factor: 22.113

3.  Wheat germ agglutinin affinity chromatography of human platelet membrane glycoproteins.

Authors:  R L Nachman; E Tarasov; B B Weksler; B Ferris
Journal:  Thromb Res       Date:  1978-01       Impact factor: 3.944

4.  Porcine Willebrand factor: a population of multimers.

Authors:  D N Fass; G J Knutson; E J Bowie
Journal:  J Lab Clin Med       Date:  1978-02

5.  Platelt membrane glycoproteins and the interaction between bovine factor VIII related protein and human platelets.

Authors:  N O Solum; I Hagen; T Gjemdal
Journal:  Thromb Haemost       Date:  1977-12-15       Impact factor: 5.249

6.  Factor VIII-associated platelet aggregation.

Authors:  E P Kirby
Journal:  Thromb Haemost       Date:  1977-12-15       Impact factor: 5.249

7.  Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.

Authors:  T R Griggs; J S Potter; S B McClanahan; W P Webster; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Platelet-aggregating factor and the aggregation of fixed washed platelets.

Authors:  H A Cooper; K W Wilkins; P R Johnson; R H Wagner
Journal:  J Lab Clin Med       Date:  1977-09

9.  Immunoinhibition of ristocetin-induced platelet aggregation.

Authors:  R L Nachman; E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

10.  Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate and protein kinase.

Authors:  R Käser-Glanzmann; M Jakäbovä; J N George; E F Lüscher
Journal:  Biochim Biophys Acta       Date:  1977-05-02
View more
  6 in total

1.  Glycoprotein Ib distribution on the surface of platelets in resting and activation states: an electron microscope study.

Authors:  H Suzuki; N Yamamoto; K Tanoue; H Yamazaki
Journal:  Histochem J       Date:  1987-03

2.  Relationship between glycocalicin and glycoprotein Ib of human platelets.

Authors:  K J Clemetson; H Y Naim; E F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

3.  Interactions between platelet-surface glycoproteins. Identification of glycoproteins capable of binding to platelet surfaces.

Authors:  D J Bowles; C Brunton
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

4.  Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.

Authors:  H A Cooper; W P Bennett; G C White; R H Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.

Authors:  J L Miller; J M Kupinski; A Castella; Z M Ruggeri
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

6.  Isolation and characterization of the major oligosaccharide of human platelet membrane glycoprotein GPIb.

Authors:  P A Judson; D J Anstee; J R Clamp
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.